Login / Signup

Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study.

Josef S SmolenLi XieBochao JiaPeter C TaylorGerd BurmesterYoshiya TanakaAyesha EliasAnabela CardosoRob OrtmannChad WallsMaxime Dougados
Published in: Rheumatology (Oxford, England) (2021)
Treatment with baricitinib 4 mg demonstrated efficacy for up to 3 years and was well tolerated.
Keyphrases
  • rheumatoid arthritis
  • combination therapy
  • high intensity
  • systemic lupus erythematosus